News
Bayer's Kerendia on course for NHS use in heart failure
Up to 280,000 people with heart failure could soon be eligible for NHS treatment with Bayer's Kerendia, following new NICE guidance.
News
Novo's Wegovy pill cleared for weight loss in EU
The EU has approved Novo Nordisk's pill formulation of weight-loss therapy Wegovy, keeping the company a step ahead of arch rival Eli Lilly.
Market Access
Preparing for the pharma fraud enforcement surge
Here is what robust, risk-based compliance looks like in 2026.
News
Celcuity gets FDA nod for first-in-class breast cancer drug
Celcuity has won FDA approval for gedatolisib – its first product – as a treatment for patients with a particular form of breast cancer.
News
FDA clears at-home start dose for Alzheimer's drug Leqembi
The FDA has cleared Eisai and Biogen's Leqembi Iqlik subcutaneous injection as a starting dose, removing the need for regular infusion clinic visits.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
